Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer

Broncy, 2019, Clinical impact of circulating tumor cells in patients with localized prostate cancer, Cells, 8, 676, 10.3390/cells8070676 Nuhn, 2019, Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology, Eur Urol, 75, 88, 10.1016/j.eururo.2018.03.028 Chung, 2020, Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review, Prostate Int, 8, 99, 10.1016/j.prnil.2020.09.001 Nagaya, 2021, RNA-seq profile of African American men with a clinically localized prostate cancer, Prostate Int, 9, 125, 10.1016/j.prnil.2020.11.002 Kwan, 2021, Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer, Prostate Int, 9, 107, 10.1016/j.prnil.2020.07.008 Pantel, 2019, Circulating tumor cells in prostate cancer: from discovery to clinical utility, Clin Chem, 65, 87, 10.1373/clinchem.2018.287102 Miyamoto, 2014, Circulating tumour cells—monitoring treatment response in prostate cancer, Nat Rev Clin Oncol, 11, 401, 10.1038/nrclinonc.2014.82 Danila, 2011, Circulating tumor cells as biomarkers in prostate cancer, Clin Cancer Res, 17, 3903, 10.1158/1078-0432.CCR-10-2650 De Bono, 2008, Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer, Clin Cancer Res, 14, 6302, 10.1158/1078-0432.CCR-08-0872 Danila, 2007, Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer, Clin Cancer Res, 13, 7053, 10.1158/1078-0432.CCR-07-1506 Antonarakis, 2014, AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer, N Engl J Med, 371, 1028, 10.1056/NEJMoa1315815 Scher, 2016, Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer, JAMA Oncol, 2, 1441, 10.1001/jamaoncol.2016.1828 Cho, 2021, Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis, Cancer Sci, 112, 859, 10.1111/cas.14745 Cho, 2020, A Direct Comparison between the Lateral Magnetophoretic Microseparator and AdnaTest for Isolating Prostate Circulating Tumor Cells, Micromachines (Basel), 11, E870, 10.3390/mi11090870 Obayashi, 2019, Initial detection of circulating tumor cells from metastatic prostate cancer patients with a novel small device, Prostate Int, 7, 131, 10.1016/j.prnil.2019.01.003 de la Taille, 1999, Int J Cancer, 84, 360, 10.1002/(SICI)1097-0215(19990820)84:4<360::AID-IJC5>3.0.CO;2-E Ennis, 1997, Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics, Cancer, 79, 2402, 10.1002/(SICI)1097-0142(19970615)79:12<2402::AID-CNCR16>3.0.CO;2-V Katz, 1995, Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer, Cancer, 75, 1642, 10.1002/1097-0142(19950401)75:7<1642::AID-CNCR2820750714>3.0.CO;2-1 Mejean, 2000, Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence, J Urol, 163, 2022 Seiden, 1994, Detection of circulating tumor cells in men with localized prostate cancer, J Clin Oncol, 12, 2634, 10.1200/JCO.1994.12.12.2634 Kantoff, 2001, Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen inmenwith hormone-refractory prostate cancer, J Clin Oncol, 19, 3025, 10.1200/JCO.2001.19.12.3025 Halabi, 2003, Prognostic significance of reverse transcriptase-polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583, J Clin Oncol, 21, 490, 10.1200/JCO.2003.04.104 Ghossein, 1997, Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma, Urology, 50, 100, 10.1016/S0090-4295(97)00127-1 Chung, 2019, Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer, Neoplasia, 21, 802, 10.1016/j.neo.2019.06.002 Qu, 2017, Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer, Clin Cancer Res, 23, 726, 10.1158/1078-0432.CCR-16-1070 Cho, 2017, A disposable microfluidic device with a reusable magnetophoretic functional substrate for isolation of circulating tumor cells, Lab Chip, 17, 4113, 10.1039/C7LC00925A Kalfazade, 2009, Quantification of PSA mRNA levels in peripheral blood of patients with localized prostate adenocarcinoma before, during, and after radical prostatectomy by quantitative real-time PCR (qRT-PCR), Int Urol Nephrol, 41, 273, 10.1007/s11255-008-9416-x Ross, 2005, Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy, Clin Cancer Res, 11, 5195, 10.1158/1078-0432.CCR-05-0431 Matsusaka, 2011, Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer, Cancer Sci, 102, 1188, 10.1111/j.1349-7006.2011.01926.x Matsusaka, 2010, Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer, Cancer Sci, 101, 1067, 10.1111/j.1349-7006.2010.01492.x Mishima, 2017, Detection of HER2 amplification in circulating tumor cells of HER2-negative gastric cancer patients, Target Oncol, 12, 341, 10.1007/s11523-017-0493-6 Liu, 2013, Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker, BMC Cancer, 13, 202, 10.1186/1471-2407-13-202 Hindson, 2011, High-throughput droplet digital PCR system for absolute quantitation of DNA copy number, Anal Chem, 83, 8604, 10.1021/ac202028g McDermott, 2013, Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR, Anal Chem, 85, 11619, 10.1021/ac403061n